会員登録
ログイン
【6190】フェニックスバイオ
PXBマウスを使った薬効試験受託。
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.03 | 2024/02/14 | Q3予 | 1,817 | → | 0.0% | -10.8% | 8 | → | 0.0% | -96.8% | 45 | → | 0.0% | -82.0% | 24 | → | 0.0% | -89.8% |
| 2024.03 | 2023/11/14 | Q2予 | 1,817 | ↓ | -10.8% | -10.8% | 8 | ↓ | -96.8% | -96.8% | 45 | ↓ | -82.0% | -82.0% | 24 | ↓ | -89.8% | -89.8% |
| 2024.03 | 2023/08/14 | Q1予 | 2,038 | → | 0.0% | 0.0% | 248 | → | 0.0% | 0.0% | 250 | → | 0.0% | 0.0% | 235 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/15 | 当初予 | 2,038 | - | - | - | 248 | - | - | - | 250 | - | - | - | 235 | - | - | - |
| 2023.03 | 2023/05/15 | 実 | 2,124 | ↑ | +5.1% | +21.3% | 508 | ↑ | +53.0% | +146.6% | 511 | ↑ | +57.2% | +142.2% | 493 | ↑ | +75.4% | +149.0% |
| 2023.03 | 2023/02/14 | Q3予 | 2,021 | ↑ | +15.4% | +15.4% | 332 | ↑ | +61.2% | +61.2% | 325 | ↑ | +54.0% | +54.0% | 281 | ↑ | +41.9% | +41.9% |
| 2023.03 | 2022/11/14 | Q2予 | 1,751 | → | 0.0% | 0.0% | 206 | → | 0.0% | 0.0% | 211 | → | 0.0% | 0.0% | 198 | → | 0.0% | 0.0% |
| 2023.03 | 2022/08/12 | Q1予 | 1,751 | → | 0.0% | 0.0% | 206 | → | 0.0% | 0.0% | 211 | → | 0.0% | 0.0% | 198 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/13 | 当初予 | 1,751 | - | - | - | 206 | - | - | - | 211 | - | - | - | 198 | - | - | - |
| 2022.03 | 2022/05/13 | 実 | 1,324 | ↑ | +1.8% | -17.1% | -167 | ↓ | -7.7% | -281.5% | -127 | ↑ | +18.6% | -239.6% | -387 | ↓ | -146.5% | -572.0% |
| 2022.03 | 2022/02/14 | Q3予 | 1,300 | → | 0.0% | -18.6% | -155 | → | 0.0% | -268.5% | -156 | → | 0.0% | -271.4% | -157 | → | 0.0% | -291.5% |
| 2022.03 | 2021/11/12 | Q2予 | 1,300 | ↓ | -18.6% | -18.6% | -155 | ↓ | -268.5% | -268.5% | -156 | ↓ | -271.4% | -271.4% | -157 | ↓ | -291.5% | -291.5% |
| 2022.03 | 2021/08/13 | Q1予 | 1,598 | → | 0.0% | 0.0% | 92 | → | 0.0% | 0.0% | 91 | → | 0.0% | 0.0% | 82 | → | 0.0% | 0.0% |
| 2022.03 | 2021/05/14 | 当初予 | 1,598 | - | - | - | 92 | - | - | - | 91 | - | - | - | 82 | - | - | - |
| 2021.03 | 2021/05/14 | 実 | 1,013 | ↑ | +2.1% | -24.7% | -276 | ↑ | +8.0% | -452.0% | -223 | ↑ | +18.3% | -502.7% | -238 | ↑ | +16.2% | -510.3% |
| 2021.03 | 2021/02/12 | Q3予 | 992 | ↓ | -26.3% | -26.3% | -300 | ↓ | -500.0% | -500.0% | -273 | ↓ | -637.8% | -637.8% | -284 | ↓ | -628.2% | -628.2% |
| 2021.03 | 2020/11/13 | Q2予 | 1,346 | → | 0.0% | 0.0% | -50 | → | 0.0% | 0.0% | -37 | → | 0.0% | 0.0% | -39 | → | 0.0% | 0.0% |
| 2021.03 | 2020/08/12 | Q1予 | 1,346 | - | - | - | -50 | - | - | - | -37 | - | - | - | -39 | - | - | - |
| 2020.03 | 2020/05/15 | 修正予 | 1,310 | ↓ | -4.2% | -22.3% | -146 | ↓ | -67.8% | -224.8% | -125 | ↓ | -119.3% | -191.2% | -415 | ↓ | -603.4% | -440.2% |
| 2020.03 | 2020/02/14 | Q3予 | 1,367 | → | 0.0% | -19.0% | -87 | → | 0.0% | -174.4% | -57 | → | 0.0% | -141.6% | -59 | → | 0.0% | -148.4% |
| 2020.03 | 2019/11/14 | Q2予 | 1,367 | ↓ | -19.0% | -19.0% | -87 | ↓ | -174.4% | -174.4% | -57 | ↓ | -141.6% | -141.6% | -59 | ↓ | -148.4% | -148.4% |
| 2020.03 | 2019/08/09 | Q1予 | 1,687 | → | 0.0% | 0.0% | 117 | → | 0.0% | 0.0% | 137 | → | 0.0% | 0.0% | 122 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/15 | 当初予 | 1,687 | - | - | - | 117 | - | - | - | 137 | - | - | - | 122 | - | - | - |
| 2019.03 | 2019/05/15 | 実 | 1,228 | ↓ | -3.8% | -18.0% | -311 | ↓ | -150.8% | -350.8% | -279 | ↓ | -146.9% | -328.7% | -297 | ↓ | -130.2% | -385.6% |
| 2019.03 | 2019/02/14 | Q3予 | 1,277 | → | 0.0% | -14.8% | -124 | → | 0.0% | -200.0% | -113 | → | 0.0% | -192.6% | -129 | → | 0.0% | -224.0% |
| 2019.03 | 2018/11/14 | Q2予 | 1,277 | ↓ | -14.8% | -14.8% | -124 | ↓ | -200.0% | -200.0% | -113 | ↓ | -192.6% | -192.6% | -129 | ↓ | -224.0% | -224.0% |
| 2019.03 | 2018/08/10 | Q1予 | 1,498 | → | 0.0% | 0.0% | 124 | → | 0.0% | 0.0% | 122 | → | 0.0% | 0.0% | 104 | → | 0.0% | 0.0% |
| 2019.03 | 2018/05/15 | 当初予 | 1,498 | - | - | - | 124 | - | - | - | 122 | - | - | - | 104 | - | - | - |
| 2018.03 | 2018/05/15 | 実 | 902 | ↓ | -1.3% | -39.1% | -268 | ↓ | -7.2% | -201.9% | -267 | ↓ | -6.8% | -201.9% | -270 | ↓ | -6.3% | -216.4% |
| 2018.03 | 2018/03/15 | 修正予 | 914 | ↓ | -26.3% | -38.2% | -250 | ↓ | -580.8% | -195.1% | -250 | ↓ | -538.6% | -195.4% | -254 | ↓ | -629.2% | -209.5% |
| 2018.03 | 2018/02/14 | Q3予 | 1,240 | → | 0.0% | -16.2% | 52 | → | 0.0% | -80.2% | 57 | → | 0.0% | -78.2% | 48 | → | 0.0% | -79.3% |
| 2018.03 | 2017/11/14 | Q2予 | 1,240 | → | 0.0% | -16.2% | 52 | → | 0.0% | -80.2% | 57 | → | 0.0% | -78.2% | 48 | → | 0.0% | -79.3% |
| 2018.03 | 2017/10/17 | 修正予 | 1,240 | ↓ | -16.2% | -16.2% | 52 | ↓ | -80.2% | -80.2% | 57 | ↓ | -78.2% | -78.2% | 48 | ↓ | -79.3% | -79.3% |
| 2018.03 | 2017/08/10 | Q1予 | 1,480 | → | 0.0% | 0.0% | 263 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% | 232 | → | 0.0% | 0.0% |
| 2018.03 | 2017/05/15 | 当初予 | 1,480 | - | - | - | 263 | - | - | - | 262 | - | - | - | 232 | - | - | - |
| 2017.03 | 2017/05/15 | 実 | 1,228 | ↓ | -3.5% | -13.6% | 142 | ↓ | -30.0% | -59.9% | 133 | ↓ | -26.1% | -61.7% | 128 | ↓ | -17.4% | -57.2% |
| 2017.03 | 2017/02/14 | Q3予 | 1,273 | → | 0.0% | -10.5% | 203 | → | 0.0% | -42.7% | 180 | → | 0.0% | -48.1% | 155 | → | 0.0% | -48.2% |
| 2017.03 | 2016/11/14 | Q2予 | 1,273 | ↓ | -10.5% | -10.5% | 203 | ↓ | -42.7% | -42.7% | 180 | ↓ | -48.1% | -48.1% | 155 | ↓ | -48.2% | -48.2% |
| 2017.03 | 2016/08/12 | Q1予 | 1,422 | → | 0.0% | 0.0% | 354 | → | 0.0% | 0.0% | 347 | → | 0.0% | 0.0% | 299 | → | 0.0% | 0.0% |
| 2017.03 | 2016/05/13 | 当初予 | 1,422 | - | - | - | 354 | - | - | - | 347 | - | - | - | 299 | - | - | - |
| 2016.03 | 2016/05/13 | 実 | 1,217 | - | - | - | 190 | - | - | - | 149 | - | - | - | 125 | - | - | - |
